Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Partially Randomized Patient Preference Trial to Assess the Quality of Life and Patency Rate After Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting: the MICS-CABG PRPP Trial

NCT04795193 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04795193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04795193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Partially Randomized Patient Preference Trial to Assess the Quality of Life and Patency Rate After Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting: the MICS-CABG PRPP Trial
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 15, 2021
Completion date
December 31, 2025
Enrollment
248 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass, off-pump, minimally invasive cardiac surgery